MEETINGS - Conference on Biological Assay Development and Validation (US) May 2002:
This article was originally published in Clinica
Executive Summary
IBC USA Conferences is hosting a conference on Biological Assay Development and Validation on May 6-8 2002 at The Argent Hotel, San Francisco, California. The conference will focus on the latest trends, techniques and capabilities of biological assays from the perspective of practising bioassay scientists. The conference will also focus on strategies to gain faster product approval. Further details from IBC USA Conferences, on tel: +1 508 616 5550; fax: +1 508 616 5522; email: [email protected] www.LifeSciencesInfo.com/2698
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.